Kiminobu Tanizawa

Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High‐Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti–Melanoma Differentiation–Associated Gene 5–Positive Dermatomyositis

Hideaki Tsuji, Ran Nakashima, Yuji Hosono et al. · Arthritis & Rheumatology · 2019 · 344 citations · Full text

Prostaglandin F2α receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-β

Toru Oga, Toshiyuki Matsuoka, Chengcan Yao et al. · Nature Medicine · 2009 · 187 citations

Inflammation, Growth Factor-β, Fibrosis +12

HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody

Kiminobu Tanizawa, Tomohiro Handa, Ran Nakashima et al. · Respiratory Medicine · 2011 · 137 citations

Clinical Immunology, Autoimmune Disease, Medicine +9

Efficacy of plasma exchange in anti-MDA5-positive dermatomyositis with interstitial lung disease under combined immunosuppressive treatment

Mirei Shirakashi, Ran Nakashima, Hideaki Tsuji et al. · Lara D. Veeken · 2020 · 132 citations

Treatment with Methotrexate and Low-dose Corticosteroids in Sarcoidosis Patients with Cardiac Lesions

Sonoko Nagai, Takafumi Yokomatsu, Kiminobu Tanizawa et al. · Internal Medicine · 2014 · 122 citations · Full text